Related by context. All words. (Click for frequent words.) 66 urothelial carcinoma 64 CYT# potent vascular disrupting 64 ovarian carcinoma 63 tPA antithrombotics anticoagulation therapy 63 prostate carcinoma 63 cytoreduction 63 Cardiopulmonary bypass 63 cisplatin resistant 62 pulmonary metastases 62 Mitomycin C 62 peritoneal carcinomatosis 62 Diffuse Large B 62 recurrent glioblastoma multiforme 62 benign prostatic hyperplasia enlarged 62 metastatic colorectal 62 Glioblastoma Multiforme 62 castration resistant hormone refractory 62 metastatic pancreatic 62 Radical prostatectomy 62 Surgical excision 61 NMIBC 61 transarterial 61 hypervascular tumors 61 esophagogastric 61 differentiated thyroid 61 metastatic malignant 61 Tumor Response 61 xenograft models 61 LHRH receptor positive 61 chronic eosinophilic leukemia 61 Decitabine 61 cervical lymph nodes 61 papillary renal cell carcinoma 61 pancreatic prostate 61 TTR amyloidosis 61 breast carcinomas 61 ovarian pancreatic 61 castrate resistant 60 Squamous Cell Carcinoma 60 squamous cell carcinoma SCC 60 behavior adrenal insufficiency 60 relapsed MM 60 castrate resistant prostate cancer 60 Follicular Lymphoma 60 Contralateral 60 recurrent metastatic 60 Vidofludimus 60 duplex ultrasonography 60 Adjuvant chemotherapy 60 histone deacetylase inhibitor 60 epithelial tumors 60 Surgical resection 60 Metastatic 60 precursor lesions 60 Heart Transplant Recipients 60 5 fluorouracil leucovorin 60 Accelerated Partial Breast Irradiation 60 investigational monoclonal antibody 59 resistant hormone refractory 59 Fludarabine 59 HBeAg negative 59 intra arterial chemotherapy 59 biliary tract cancer 59 Gleevec resistant 59 erlotinib Tarceva ® 59 surgical debulking 59 gastrointestinal stromal tumors GIST 59 lung pancreatic 59 FUSILEV enhances 59 cytotoxic therapies 59 leiomyomas 59 dasatinib Sprycel 59 Hepatocellular Carcinoma HCC 59 Occlusive Disease 59 prostate cancer PCa 59 artery embolization 59 DVT prophylaxis cholesterol 59 paclitaxel poliglumex 59 nodal metastasis 59 Mantle Cell Lymphoma 59 receptor tyrosine kinase inhibitor 59 Stereotactic Body Radiation Therapy 59 corticosteroid therapy 59 Coronary Artery Bypass Graft 59 subconjunctival injection 59 Peripheral Arterial 59 Fludara ® 59 Embolization 59 acetonide FA 59 recurrent NSCLC 59 deCODE ProstateCancer TM 59 renal tumors 59 colorectal carcinoma 59 ACTEMRA TM 59 HER2 positive cancers 59 Trastuzumab 59 Acute myeloid leukemia 59 malignant ascites 59 immunosuppressive regimens 59 FOLFOX chemotherapy 59 hepatorenal syndrome 59 investigational immunotherapy 58 rhabdoid 58 dasatinib Sprycel ® 58 follicular lymphoma FL 58 liver metastasis 58 cisplatin chemotherapy 58 GRNOPC1 contains 58 refractory colorectal cancer 58 noninvasive outpatient 58 intimal hyperplasia 58 FDG uptake 58 Estrogen Receptor 58 ovarian lung 58 fibrin deposition 58 androgen ablation 58 tumors GIST 58 thoracoscopic lobectomy 58 HIPEC 58 interferon ribavirin 58 chemoradiation therapy 58 antiangiogenic therapy 58 refractory prostate cancer 58 KRAS mutation 58 Metastases 58 orchiectomy 58 lymphatic mapping 58 transplantation HCT 58 mRCC 58 adalimumab Humira 58 bladder ovarian 58 Papillary 58 skeletal metastases 58 Glioblastoma Multiforme GBM 58 chemotherapy docetaxel 58 preoperative chemotherapy 58 metastatic bladder 58 CA4P 58 virologic responses 58 forodesine 58 nonmetastatic 58 Nonsurgical 58 thalidomide Thalomid 58 recurrent glioblastoma 58 BRCA mutation carriers 58 novel VDA molecule 58 Intensity Modulated 58 rituximab Rituxan 58 prostate cancer CaP 58 leukemia AML 58 spinal metastases 58 intradermal injection 57 CHOP chemotherapy 57 osteoporotic compression fractures 57 lenalidomide Revlimid R 57 liver resection 57 adjuvant radiotherapy 57 IMC #B 57 Cutaneous T 57 Radiofrequency Ablation RFA 57 debulking surgery 57 postoperative chemotherapy 57 trastuzumab Herceptin ® 57 Minimally Invasive Procedure 57 Degarelix 57 Combination therapy 57 chemoradiotherapy 57 hepatocellular cancer 57 doublet chemotherapy 57 premalignant 57 assessing T DM1 57 CT Angiography 57 concurrent chemoradiation 57 esophageal gastric 57 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 57 Peginterferon alfa 2b 57 completely resected 57 follicular non 57 HGS ETR1 mapatumumab 57 Belldegrun 57 superficial bladder cancer 57 PSMA ADC 57 bevacizumab Avastin ® 57 refractory chronic myeloid 57 stage IIIB 57 Aflibercept 57 Hypertrophy 57 5 FU leucovorin 57 adrenocortical cancer 57 metaplasia 57 radiation chemoradiation 57 myelofibrosis polycythemia vera 57 pelvic lymphadenectomy 57 mitomycin C 57 Radiofrequency ablation 57 cutaneous squamous cell carcinoma 57 thyroid nodules 57 recurrent malignant glioma 57 gefitinib Iressa 57 Cell Lymphoma CTCL 57 grade squamous intraepithelial 57 Carfilzomib 57 radiotherapy RT 57 refractory indolent non 57 Cystectomy 57 cytoreductive surgery 57 CINQUIL 57 PEGPH# 57 lung carcinomas 57 haematologic 57 transurethral resection 57 activating mutation 57 Xelox 57 imatinib Gleevec 57 uterine tumors 57 lymphadenectomy 57 HNSCC 57 metastatic GIST 57 Motesanib 57 pancreatic gastric 57 fibroma 57 refractory chronic lymphocytic 57 Cryosurgery 57 moderate renal impairment 57 OHR/AVR# 57 wedge resection 57 Kinoid 57 advanced metastatic renal 57 HER2 positive metastatic breast 57 ErbB2 positive 57 photorefractive keratectomy PRK 57 relapsing remitting MS RRMS 57 Introgen ADVEXIN 57 sunitinib Sutent 57 leiomyoma 57 chronic idiopathic thrombocytopenic purpura 57 malignant cancerous 57 familial amyloidotic polyneuropathy FAP 57 VALSTAR TM 57 Recurrent Chest Wall 57 Idiopathic Pulmonary Fibrosis 57 Bezielle 57 pancreatic adenocarcinoma 57 Colon polyps 56 irinotecan chemotherapy 56 TLIF 56 stereotactic radiotherapy 56 Liver transplantation 56 CIN2 + 56 BRCA deficient 56 Simulect 56 Lung transplantation 56 colorectal cancer liver metastases 56 allogeneic hematopoietic stem cell 56 refractory Hodgkin 56 SIR Spheres 56 Pegylated Interferon 56 MALT lymphoma 56 colorectal liver metastases 56 Kit CD# positive 56 prokinetic agent 56 transarterial chemoembolization 56 ritonavir boosted 56 herpetic keratitis 56 mutated K ras 56 Irinotecan 56 nephrectomies 56 pulmonary artery banding 56 Prostate Tumors 56 Myelodysplastic Syndrome 56 cutaneous T 56 vaginal hysterectomy 56 immune modulating 56 hematological parameters 56 Resection 56 ischemic mitral regurgitation 56 PegIFN 56 deCODE BreastCancer 56 evaluating tivozanib 56 chemo resistant 56 colorectal lung 56 adjuvant radiation 56 K RAS 56 Endometrial 56 Gleevec imatinib mesylate 56 medically inoperable 56 docetaxel Taxotere ® 56 allogeneic HSCT 56 Breast Tumors 56 BRIM2 56 Bone marrow transplant 56 deep venous thromboses 56 Renal Cell Carcinoma RCC 56 antitumor effect 56 Pressure Monitoring 56 liposomal amphotericin B 56 mycosis fungoides 56 urethral bulking agent 56 benign neoplasms 56 ThermoDox R 56 samalizumab 56 FDG-PET/CT 56 angiogenesis inhibitor 56 atypical Hemolytic Uremic Syndrome 56 vein ablation 56 hyperplastic 56 alfa 2a 56 Amrubicin 56 endocrine therapies 56 Menopausal hormone therapy 56 Sentinel Lymph Node Biopsy 56 Doxil ® 56 huN# DM1 56 Alessandro Riva 56 paclitaxel Taxol ® 56 Pemetrexed 56 neuroendocrine cancers 56 Carcinoma 56 autoantibody levels 56 fallopian tube carcinoma 56 FOLFOX6 56 Prostatectomy 56 Cytarabine 56 perioperatively 56 clinically localized prostate 56 antiretroviral naïve 56 bone marrow aspiration 56 infusional 56 paclitaxel cisplatin 56 metastatic gastric 56 recurrent glioblastoma multiforme GBM 56 perioperative morbidity 56 Less Invasive 56 radiation therapy SBRT 56 oral clodronate 56 refractory NSCLC 56 keratectomy 56 Clot busting 56 serologically active systemic lupus 56 cholangiocarcinoma 56 phase IIb study 56 Stereotactic body 55 basiliximab 55 PNP inhibitor 55 clodronate 55 extrapleural pneumonectomy 55 evaluating picoplatin 55 FOLFIRI alone 55 neoadjuvant therapy 55 HGS# 55 luteinizing hormone releasing 55 breast carcinoma 55 Basal cell 55 repigmentation 55 metastatic lesions 55 Nodules 55 basal cell cancers 55 gastrointestinal stromal tumor GIST 55 Toxicities 55 mycophenolate mofetil MMF 55 TNF alpha antagonist 55 tumor xenograft models 55 unfavorable cytogenetics 55 alvespimycin 55 antithrombotic therapy 55 tumor angiogenesis inhibitors 55 Helicobacter pylori eradication 55 indolent NHL 55 abnormal cytology 55 chronic myeloid 55 dysplastic lesions 55 antifungal therapy 55 EGFR expressing 55 thymic carcinoma 55 Lumpectomy 55 mutated KRAS gene 55 vascular insufficiency 55 imatinib therapy 55 intra arterial 55 tumor resection 55 via intradermal injections 55 Computed tomography 55 CytoCore develops cost 55 anaplastic 55 adenomatous 55 JAK2 V#F 55 vitreous floaters 55 microsphere therapy 55 thetreatment 55 recurrent squamous cell carcinoma 55 antiplatelet therapies 55 acyclovir Lauriad R 55 vinca alkaloid 55 metastatic malignant melanoma 55 gemcitabine Gemzar ® 55 Breast conserving 55 squamous cell lung cancer 55 Etanercept 55 malignant growths 55 probe amplification MLPA 55 seminoma 55 transrectal ultrasound guided 55 Hypertensive adverse reactions 55 CIMZIA TM 55 prostate TURP 55 Spinal Fusion 55 Phase #b/#a clinical 55 Azedra 55 congenital toxoplasmosis 55 smoldering multiple myeloma 55 noninvasive painless 55 malignant pleural mesothelioma 55 lipomas 55 LungAlert TM 55 endoscopic resection 55 monoclonal antibody conjugated 55 EGFR TKI 55 gemcitabine carboplatin 55 ovarian breast 55 systemic fungal infections 55 hormone refractory 55 squamous intraepithelial lesions 55 dyskeratosis congenita 55 advanced hepatocellular carcinoma 55 cell carcinoma RCC 55 REMINDER ORLive Presents 55 refractory ovarian cancer 55 sunitinib malate 55 Levels Linked 55 surgical resection cavity 55 multi kinase inhibitor 55 Selective Internal 55 Evoltra ® 55 dimensional conformal radiotherapy 55 bony metastases 55 Proxinium TM 55 imatinib Gleevec ® 55 endometrial cancers 55 treatmentof 55 adrenalectomy 55 F FDG PET 55 bladder prostate 55 Aplidin 55 neoadjuvant chemotherapy 55 video assisted thoracoscopic 55 de novo kidney transplant 55 curability 55 polypoid 55 Radiofrequency Ablation 55 transabdominal 55 refractory metastatic 55 Dose Reduction 55 EOquin TM 55 repair TEVAR 55 visilizumab 55 grade cervical intraepithelial 55 hematological diseases 55 mapatumumab 55 IgG1 monoclonal antibody 55 Alequel 55 diffuse intrinsic pontine glioma 55 heavily pretreated 55 subependymal giant cell 55 Epratuzumab 55 lymph node removal 55 grade gliomas 55 Carotid endarterectomy 55 KRAS mutant 55 platinum refractory 55 HALO# [002] 55 Cryoablation 55 colorectal cancer CRC 55 conventional DMARDs 55 occlusive disease 55 IV NSCLC 55 serous ovarian cancer 55 ZACTIMA 55 metastatic relapsed 55 either acutely decompensated 55 Osteoporosis Drugs 55 stage IIIb IV 55 paclitaxel Taxol R 55 operable breast cancer 55 Mitoxantrone 55 combinability 55 pelvic malignancies 55 gastrointestinal stromal tumor 55 Acute Myelogenous Leukemia AML 55 gastric carcinoma 55 pancreatic carcinoma 55 Annamycin 55 trastuzumab Herceptin R 55 PSADT 55 multimodality therapy 55 transesophageal echocardiography 55 Intracranial Aneurysms 55 resectable 55 acute GvHD 55 prostate bladder 55 Aortic Valve 55 colonoscopy sigmoidoscopy 55 androgen suppression 55 alkylating agent 55 Acute Myeloid Leukaemia AML 55 Vandetanib 55 endobronchial 55 Adjunctive 55 histologies 55 unresectable liver cancer 55 mucinous 55 hemodialysis peritoneal dialysis 55 MAGE A3 ASCI 55 coronary arteriography 55 CLL SLL 55 Cloretazine 55 salpingo oophorectomy 55 primitive neuroectodermal tumor 55 Patients Undergoing 55 seminomas 55 immunosuppression therapy 55 Endologix Powerlink System 55 malignant lymphoma 55 Hormonal therapy 55 postexposure 55 immunotherapeutic agent 55 metastatic renal cell carcinoma 55 PANVAC VF 55 aneurysms AAA 54 hematological disorders 54 lung malignant melanoma 54 Bevacizumab Avastin 54 prostate cancer HRPC 54 neoadjuvant treatment 54 SIADH 54 Vicinium TM 54 balloon valvuloplasty 54 alveolar rhabdomyosarcoma 54 loop electrosurgical excision 54 pancreatectomy 54 immunomodulatory therapy 54 ductal adenocarcinoma 54 endoscopic biopsy 54 Hematologic toxicity 54 visit www.rtanswers.org 54 sorafenib tablets 54 antibody MAb 54 Genasense ® 54 therapy IMRT 54 axillary lymph node dissection 54 Akt activation 54 intravesical therapy 54 HuMax EGFr 54 anti leukemic 54 grade glioma 54 Hydroxyurea 54 Cloretazine R 54 leukemia APL 54 Unfractionated Heparin 54 GIST tumors 54 glioblastoma multiforme GBM 54 paragangliomas 54 functional mitral regurgitation 54 IMA# 54 radiolabeled TM# 54 immunochemical 54 colorectal ovarian 54 Intravenous immunoglobulin 54 prostate cancer mCRPC 54 extracranial 54 cervical prostate 54 phase IIb clinical 54 AF ablation procedures 54 ALA PDT 54 EndoTAGTM 1 54 abdominal computed tomography 54 colorectal adenocarcinoma 54 rALLy 54 follicular NHL 54 radical nephrectomy 54 cystectomy 54 aflibercept VEGF Trap 54 MGd 54 induced anemia 54 anti angiogenic agents 54 Malignant pleural mesothelioma 54 treat menorrhagia 54 cystoscopic 54 neuroblastoma tumor 54 renal cell carcinomas 54 EGFR mutation positive 54 lymph node dissection 54 GORE TAG Device 54 blastic phase 54 thymectomy 54 Radiation Therapy SIRT 54 transurethral 54 KRAS wild 54 IMC A# 54 leukemia lymphoma multiple myeloma 54 doxorubicin cyclophosphamide 54 lenalidomide dexamethasone 54 endovascular stent graft 54 multiple myeloma MM 54 postoperative morbidity 54 latent tuberculosis TB 54 intensity modulated 54 antitumor activity 54 telomerase inhibition 54 EVIZON TM 54 Natalizumab 54 Lumbar Interbody Fusion 54 KRAS mutations occur 54 esophagogastroduodenoscopy 54 bilateral orchiectomy 54 refractory AML 54 Mammographic 54 HER2 positive 54 recurrent bladder 54 glomerular filtration 54 immunosuppressive therapies 54 flavopiridol 54 myeloablative 54 Zoledronic acid 54 underwent surgical resection 54 noninvasive ultrasound 54 sentinel lymph node biopsy 54 unresectable 54 basal cell skin 54 neutropenic patients 54 autoimmune uveitis 54 myocardial revascularization 54 minimally symptomatic 54 Metastatic Colorectal Cancer 54 Treatment Reduces 54 Virtual Colonoscopy 54 pediatric malignancies 54 pegylated liposomal doxorubicin 54 BRAF inhibitor 54 ELACYT 54 NSCLC tumors 54 Platinol ® cisplatin 54 intensity modulated radiotherapy 54 prednisone prednisolone 54 CD# mAb 54 Erlotinib 54 parathyroid carcinoma 54 Temodar ® 54 TRAIL induced apoptosis 54 breast pancreatic 54 Mohs micrographic surgery 54 Aggressive Prostate Cancer 54 peritoneal cancer 54 pheochromocytoma 54 imatinib resistant 54 Prostate specific antigen 54 EGFR tyrosine kinase inhibitors 54 removed laparoscopically 54 chronic thromboembolic pulmonary 54 neoadjuvant radiation 54 Uterine fibroid embolization 54 pan HDAC inhibitor 54 thrombocytopenic 54 lung metastases 54 Percutaneous Transluminal Coronary Angioplasty 54 Androgen Deprivation 54 uterine fibroid embolization 54 CT Colonography 54 TTF Therapy 54 androgen independent 54 Breast Specific 54 nodal metastases 54 ganetespib 54 DMARD therapy 54 Nephrectomy 54 adjuvant cisplatin 54 hepatic resection 54 Exherin TM 54 weekly subcutaneous injections 54 Stereotactic radiosurgery 54 OvaRex MAb 54 AVASTIN 54 metastatic HER2 positive 54 surgically resectable 54 Balloon sinuplasty 54 bone marrow biopsies 54 relapsed ovarian cancer 54 prostate cancer CRPC 54 HIV coinfected 54 hematological toxicity 54 radiofrequency ablation RFA 54 previously untreated follicular 54 node dissection 54 denervation 54 PEG interferon 54 Gemcitabine 54 androgen deprivation 54 gemcitabine Gemzar 54 acute leukemias 54 TNF inhibitor therapy 54 lymphocytic leukemia 54 radiochemotherapy 54 papillary RCC 54 IRX 2 54 transthoracic 54 IL# PE#QQR 54 adriamycin 54 calcaneal fractures 54 Regenerative Cells 54 histologically confirmed 54 IFN α 54 specific antigen PSA 54 nonmyeloablative 54 depsipeptide 54 keloid 54 precancerous cervical 54 asymptomatic hyperuricemia 54 guided percutaneous 54 corticosteroid dexamethasone 54 daunorubicin 54 bladder tumors 54 adjuvant therapies 54 carcinoid 54 carcinoid tumors 54 carcinoma HCC 54 pancreatic NET 54 thrombocytosis 54 lymphatic tissue 53 Ultrasonography 53 UPPP 53 Pap smears mammograms 53 Folfox 53 carcinoid tumor 53 MDS AML 53 gynecologic procedures 53 malignant pheochromocytoma 53 axillary dissection 53 androgen ablation therapy 53 Afatinib 53 olaparib 53 ultrasonographic examination 53 intra abdominal infections 53 Biopsy System 53 Radio Frequency Ablation 53 colonoscopic 53 alefacept 53 perioperative complications 53 metastatic colorectal carcinoma 53 endometrial carcinoma 53 Transurethral Resection 53 Ozarelix 53 Sorafenib 53 FOLOTYN ® 53 nephrectomy 53 sorafenib Nexavar 53 elacytarabine 53 postoperative AF 53 riociguat 53 anthracycline chemotherapy 53 colon resection 53 Virulizin ® 53 recurrent ovarian cancer 53 Vagus nerve stimulation 53 TMP SMX 53 intraductal 53 cytologic 53 Retreatment 53 thymoma 53 Duodenal 53 diabetic retinopathy DR 53 TroVax ® 53 urine cytology 53 Phase Ib II 53 proton MR spectroscopy 53 registrational trial 53 abdominal hysterectomy 53 renal carcinoma 53 patients undergoing chemotherapy 53 hypofractionated 53 underwent resection 53 colon esophageal 53 including acne photodamage 53 Endometrial ablation 53 detect precancerous lesions 53 invasive biopsy 53 malabsorptive 53 hematologic toxicity 53 chemotherapy cisplatin 53 intensive statin therapy 53 Minimally Invasive Treatment 53 multiorgan 53 invasive lobular carcinoma 53 abiraterone acetate 53 gastroesophageal junction 53 Recurrences 53 transfusion syndrome 53 autoantibody positive 53 Breast Biopsies 53 gastric cancers 53 Bankart lesion 53 venous stasis ulcers 53 ORLive Presents 53 uterus fallopian tubes 53 tibial plateau fractures 53 retroperitoneal 53 radical cystectomy 53 pain palliation 53 lymphoma subtypes 53 antimicrobial prophylaxis 53 photocoagulation 53 Mammosite 53 demethylation 53 unresectable stage 53 taxane therapy 53 dose escalation phase 53 inhaled bronchodilators 53 tumor subtypes 53 metastatic castrate resistant 53 IV metastatic melanoma 53 upper endoscopy 53 cilengitide 53 fitball courses 53 colorectal pancreatic 53 superficial basal cell carcinoma 53 mitoxantrone plus 53 Dural Sealant 53 angiography CTA 53 Coronary angiography 53 contralateral breast 53 biliary tract 53 antibiotic prophylaxis 53 tamoxifen Nolvadex ® 53 trastuzumab DM1 T DM1 53 SCCHN 53 Carbaglu ® 53 dirucotide MBP# 53 non hodgkin lymphoma 53 Cytoxan 53 symptomatic hyponatremia 53 immunochemical fecal occult 53 HER2 negative 53 AA Amyloidosis 53 vestibular schwannomas 53 relapsed multiple myeloma 53 dysplastic nevi 53 axillary nodes 53 percutaneous drainage 53 iPTH 53 Organ Rejection 53 chemoresistant 53 temsirolimus 53 epithelial ovarian cancer 53 advanced HER2 positive 53 uric acid lowering 53 Abciximab 53 cyclophosphamide chemotherapy 53 EGFR inhibitors 53 immunological responses 53 Anti Bacterial Envelope 53 Cell Lung Cancer 53 liposomal doxorubicin 53 fecal immunochemical test 53 ixabepilone 53 cell lymphoma CTCL 53 detecting colorectal cancer 53 nasopharyngeal carcinoma 53 lupus nephritis 53 non resectable liver 53 cranial radiation 53 coronary computed tomography 53 Medullary thyroid cancer 53 MMP inhibitors 53 Oxaliplatin 53 NovoTTF #A System 53 MRgFUS 53 telaprevir dosed 53 leiomyosarcoma 53 IL 1ß 53 recovery CRp 53 Occlusion 53 Syndrome LEMS 53 needle aspiration 53 pouchitis 53 folinic acid 53 RhuDex R 53 RCW breast cancer 53 tumor regressions 53 Nexavar sorafenib 53 benign biliary strictures 53 unstable angina UA 53 Perifosine 53 locoregional 53 rtPA 53 Quinamed 53 Pre implantation genetic 53 HGS ETR1 53 GISTs 53 decompensated cirrhosis 53 conformal radiation therapy 53 cancer mCRC 53 melanoma tumors 53 refractory acute myeloid 53 LUX Lung 53 pemphigus vulgaris 53 Minimally invasive 53 pegylated interferon alpha 53 Vidaza azacitidine 53 paclitaxel carboplatin 53 orchidectomy 53 stem cell transplantations 53 8mg/kg 53 Glioblastoma multiforme 53 Kidney Tumors 53 etoposide 53 nonhereditary 53 pulmonary hypertension PH 53 cytogenetic response 53 Intubation 53 endothelin receptor antagonists 53 Carotid artery 53 pancreatic ovarian 53 Chronic lymphocytic leukemia 53 mCRC patients 53 immunosuppressive regimen 53 basal cell carcinoma BCC 53 haematological cancers 53 Chronic Lymphocytic Leukemia 53 metastatic castration resistant 53 trans retinoic acid 53 adenocarcinomas 53 leukemia myeloma 53 Phacoemulsification 53 endoscopic ultrasonography 53 immunodeficiency disorders 53 Intravascular 53 Mohs surgery 52 palliative radiotherapy 52 fibroadenomas 52 pancreatic colorectal 52 relapsed refractory multiple myeloma 52 Inflammatory breast cancer 52 CIMZIA ™ 52 serum calcium levels 52 ovarian malignancy 52 pegfilgrastim 52 C1 INH deficiency 52 invasive candidiasis 52 tumor lysis syndrome 52 sorafenib Nexavar ® 52 urethral strictures 52 Nimotuzumab 52 peritumoral 52 intravenous cyclophosphamide 52 metastatic ovarian cancer 52 biochemical relapse 52 guaiac 52 Tamibarotene 52 histone deacetylase HDAC inhibitor 52 postoperative radiotherapy 52 treating neuropathic pain 52 Ivanhoe Newswire Patients 52 esophageal resection 52 Radiation Dose 52 uterine cervix 52 HER2 positive breast 52 gastrectomy 52 D Dimer 52 bi lateral mastectomy 52 neointimal hyperplasia 52 factor TNF 52 myomas 52 PROSTVAC ® 52 cervical carcinoma 52 LHRH agonists 52 fine needle aspirate 52 symptomatic paroxysmal AF 52 benign prostatic hypertrophy BPH 52 PAP smears 52 alpha blocker 52 HRPC 52 anticoagulants blood thinners 52 Sustained Reduction 52 Insegia 52 chronic hemodialysis 52 mutated KRAS 52 systemic ALCL 52 myoma 52 LHRH analogues 52 chemo radiotherapy 52 neoadjuvant 52 docetaxel chemotherapy 52 LHRH agonist 52 non alcoholic steatohepatitis 52 artery stenosis 52 bortezomib Velcade 52 Spinal Fractures 52 interferon IFN 52 oropharyngeal candidiasis OPC 52 Uterine artery embolization 52 patient derived xenografts